Fig. 5
From: Fibrinogen alpha and beta chains as non-invasive predictors of hepatocellular carcinoma progression
Identification of fibrinogen family and AFP combinations and diagnostic validity of biomarkers. (A) AUCs of dual marker combinations for non-tumor (NT) versus HCC subgroups (left). AUCs of dual marker combination for high-risk group (CH/LC) versus HCC subgroups (right). (B) AUCs of triplet marker combinations for non-tumor (NT) versus HCC subgroups (left). AUCs of triplet marker combination for high-risk group (CH/LC) versus HCC subgroups (right). (C) Analysis of individual and combined marker positivity rates in 158 patients with HCC. (D) Correlation between the FGA, FGB, and FGG levels and liver functional markers.
